Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients

NCT05136833 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Covid-19 pandemia

Conditions

Tuberculosis

Interventions

BIOLOGICAL: RUTI® vaccine
BIOLOGICAL: Placebo

Sponsor

Archivel Farma S.L.

Collaborators

[object Object]